Ginkgo Bioworks Holdings Inc (NYSE:DNA) price on current trading day, rose 3.85% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $14.69.
A look at the stock’s price movement, the level at last check in today’s session was $14.14, moving within a range at $13.4116 and $15.475. The beta value (5-Year monthly) was 1.49. Turning to its 52-week performance, $16.85 and $5.00 were the 52-week high and 52-week low respectively. Overall, DNA moved 59.79% over the past month.
Ginkgo Bioworks Holdings Inc’s market cap currently stands at around $859.54 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Jun-13.
Turning to the stock’s technical picture we see that short term indicators suggest on average that DNA is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
5 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 2 recommend DNA as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 2 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
DNA’s current price about 31.27% and 58.15% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 75.97, while 7-day volatility ratio is 11.49% and 9.48% in the 30-day chart. Further, Ginkgo Bioworks Holdings Inc (DNA) has a beta value of 1.53. Analysts have given the company’s stock an average 52-week price target of $6.5, forecast between a low of $4.35 and high of $12. Looking at the price targets, the low is 70.39% off recent price level in today’s trading while to achieve the yearly target high, it has to move 18.31%. Nonetheless, investors will most likely welcome a 55.75% jump to $6.5 which is the analysts’ median price.
If we refocus on Ginkgo Bioworks Holdings Inc (NYSE:DNA), historical trading data shows that trading volumes averaged 1.81 over the past 10 days and 1.36 million over the past 3 months. The company’s latest data on shares outstanding shows there are 43.08 million shares.
The 31.28% of Ginkgo Bioworks Holdings Inc’s shares are in the hands of company insiders while institutional holders own 56.82% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 12.02 million on 2025-06-30, giving us a short ratio of 8.32. The data shows that as of 2025-06-30 short interest in Ginkgo Bioworks Holdings Inc (DNA) stood at 2663.0 of shares outstanding, with shares short rising to 11.82 million registered in 2025-05-30. Current price change has pushed the stock 28.32% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the DNA stock continues to rise going into the next quarter.
